Roth Capital Starts ChromaDex (CDXC) at Buy

March 8, 2022 7:07 AM EST Send to a Friend
Roth Capital analyst Sean McGowan initiates coverage on ChromaDex (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login